Fractal Investments LLC Decreases Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Fractal Investments LLC trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 12,601 shares of the company’s stock after selling 1,399 shares during the quarter. GE HealthCare Technologies accounts for about 0.2% of Fractal Investments LLC’s investment portfolio, making the stock its 22nd biggest position. Fractal Investments LLC’s holdings in GE HealthCare Technologies were worth $974,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of GEHC. Chicago Capital LLC grew its stake in GE HealthCare Technologies by 2.8% in the third quarter. Chicago Capital LLC now owns 6,081 shares of the company’s stock worth $414,000 after purchasing an additional 163 shares in the last quarter. Chilton Capital Management LLC increased its holdings in shares of GE HealthCare Technologies by 15.4% in the 4th quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock valued at $95,000 after acquiring an additional 164 shares during the last quarter. Procyon Advisors LLC increased its holdings in shares of GE HealthCare Technologies by 5.2% in the 4th quarter. Procyon Advisors LLC now owns 3,555 shares of the company’s stock valued at $275,000 after acquiring an additional 175 shares during the last quarter. Meeder Advisory Services Inc. raised its position in shares of GE HealthCare Technologies by 5.4% during the 4th quarter. Meeder Advisory Services Inc. now owns 3,634 shares of the company’s stock valued at $281,000 after acquiring an additional 185 shares in the last quarter. Finally, Forum Financial Management LP lifted its stake in GE HealthCare Technologies by 3.9% during the third quarter. Forum Financial Management LP now owns 4,989 shares of the company’s stock worth $339,000 after purchasing an additional 186 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC traded up $0.48 on Wednesday, hitting $86.72. The company’s stock had a trading volume of 2,017,387 shares, compared to its average volume of 3,341,176. The company has a market capitalization of $39.57 billion, a price-to-earnings ratio of 28.72, a price-to-earnings-growth ratio of 2.93 and a beta of 0.94. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50. The stock’s 50-day moving average is $88.91 and its two-hundred day moving average is $78.27.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The firm had revenue of $5.20 billion during the quarter, compared to analyst estimates of $5.09 billion. During the same quarter in the prior year, the firm posted $1.31 EPS. GE HealthCare Technologies’s revenue was up 5.3% compared to the same quarter last year. On average, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s payout ratio is 3.97%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on GEHC. Argus boosted their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. HSBC assumed coverage on shares of GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 target price on the stock. Mizuho increased their price target on GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, April 11th. Citigroup raised their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Finally, Morgan Stanley upped their price objective on GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a research note on Monday, February 12th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $95.09.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.